Applied

Type

Modification

Confidence

100%

Created

Apr 14, 2026

Evidence

1 source

Rationale

Tal specifically flagged the AAA Background section for still showing the outdated Wanhainen 2019 citation. This update replaces that outdated ESVS 2019 AAA guideline citation with the current 2024 ESVS editor's-choice AAA guideline and also adds the same current guideline to the screening/surveillance sentence so the visible Background section reflects the up-to-date ESVS source without changing the substantive text.

Content Changes

Aneurysmal disease spans abdominal ([[abdominal aortic aneurysm (AAA)]]), thoracic ([[TAA]]), thoracoabdominal ([[TAAA]]), and peripheral arterial beds [@esc2014] and remains a leading cause of sudden vascular death due to rupture. AAA prevalence in men ≥65 years is approximately 1.5–4.5% [@wanhainen2019][@esvs2024-editors] and lower in women, who have higher rupture risk at smaller diameters [@svs2018]. Thoracic aneurysms are less common but carry high lethality, particularly in connective tissue disorders (Marfan, Loeys–Dietz, vascular Ehlers–Danlos) [@esc2014]. Peripheral aneurysms (popliteal, femoral, visceral, renal) often coexist with AAA [@dawson1997]. Population screening of older men reduces AAA-related mortality and emergent repairs, and contemporary guidelines define who to screen and how to surveil detected AAAs [@mass2002] [@svs2018] [@esc2014].[@esc2014] [@esvs2024-editors]. For peripheral arterial disease management, see [[PAD]].

Reviewer Notes

Approve targeted fix for Tal's AAA background report: replace outdated Wanhainen 2019 inline guideline citation with the current 2024 ESVS AAA editor's-choice guideline in the exact Background section he flagged.